Literature DB >> 11342634

The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.

E Z Tchilian1, D L Wallace, N Imami, H X Liao, C Burton, F Gotch, J Martinson, B F Haynes, P C Beverley.   

Abstract

The leukocyte common (CD45) Ag is essential for normal T lymphocyte function and alternative splicing at the N terminus of the gene is associated with changes in T cell maturation and differentiation. Recently, a statistically significant association was reported in a large series of human thymus samples between phenotypically abnormal CD45 splicing and the presence of the CC chemokine receptor 5 deletion 32 (CCR5del32) allele, which confers resistance to HIV infection in homozygotes. We show here that abnormal splicing in these thymus samples is associated with the presence of the only established cause of CD45 abnormal splicing, a C77G transversion in exon A. In addition we have examined 227 DNA samples from peripheral blood of healthy donors and find no association between the exon A (C77G) and CCR5del32 mutations. Among 135 PBMC samples, tested by flow cytometric analysis, all those exhibiting abnormal splicing of CD45 also showed the exon A C77G transversion. We conclude that the exon A (C77G) mutation is a common cause of abnormal CD45 splicing and that further disease association studies of this mutation are warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342634     DOI: 10.4049/jimmunol.166.10.6144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Authors:  Angelino T Tromp; Michiel Van Gent; Pauline Abrial; Amandine Martin; Joris P Jansen; Carla J C De Haas; Kok P M Van Kessel; Bart W Bardoel; Elisabeth Kruse; Emilie Bourdonnay; Michael Boettcher; Michael T McManus; Christopher J Day; Michael P Jennings; Gérard Lina; François Vandenesch; Jos A G Van Strijp; Robert Jan Lebbink; Pieter-Jan A Haas; Thomas Henry; András N Spaan
Journal:  Nat Microbiol       Date:  2018-05-07       Impact factor: 17.745

2.  A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31.

Authors:  Bo Johanneson; Guadalupe Lima; Jenny von Salomé; Donato Alarcón-Segovia; Marta E Alarcón-Riquelme
Journal:  Am J Hum Genet       Date:  2002-10-08       Impact factor: 11.025

3.  Unusual case presentations associated with the CD45 C77G polymorphism.

Authors:  E Z Tchilian; J Gil; M L Navarro; E Fernandez-Cruz; H Chapel; S Misbah; B Ferry; H Renz; R Schwinzer; P C L Beverley
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

Review 4.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

5.  Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.

Authors:  Enrico M Trecarichi; Mario Tumbarello; Katleen de Gaetano Donati; Enrica Tamburrini; Roberto Cauda; Christina Brahe; Francesco D Tiziano
Journal:  AIDS Res Ther       Date:  2006-09-25       Impact factor: 2.250

6.  C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.

Authors:  Johannes Landskron; Sigrid M Kraggerud; Elisabeth Wik; Anne Dørum; Merete Bjørnslett; Espen Melum; Øystein Helland; Line Bjørge; Ragnhild A Lothe; Helga B Salvesen; Kjetil Taskén
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 7.  Alternative Splicing of Pre-mRNA in the Control of Immune Activity.

Authors:  Zhongjing Su; Dongyang Huang
Journal:  Genes (Basel)       Date:  2021-04-15       Impact factor: 4.096

8.  Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.

Authors:  Soumya Raychaudhuri; Brian P Thomson; Elaine F Remmers; Stephen Eyre; Anne Hinks; Candace Guiducci; Joseph J Catanese; Gang Xie; Eli A Stahl; Robert Chen; Lars Alfredsson; Christopher I Amos; Kristin G Ardlie; Anne Barton; John Bowes; Noel P Burtt; Monica Chang; Jonathan Coblyn; Karen H Costenbader; Lindsey A Criswell; J Bart A Crusius; Jing Cui; Phillip L De Jager; Bo Ding; Paul Emery; Edward Flynn; Pille Harrison; Lynne J Hocking; Tom W J Huizinga; Daniel L Kastner; Xiayi Ke; Fina A S Kurreeman; Annette T Lee; Xiangdong Liu; Yonghong Li; Paul Martin; Ann W Morgan; Leonid Padyukov; David M Reid; Mark Seielstad; Michael F Seldin; Nancy A Shadick; Sophia Steer; Paul P Tak; Wendy Thomson; Annette H M van der Helm-van Mil; Irene E van der Horst-Bruinsma; Michael E Weinblatt; Anthony G Wilson; Gert Jan Wolbink; Paul Wordsworth; David Altshuler; Elizabeth W Karlson; Rene E M Toes; Niek de Vries; Ann B Begovich; Katherine A Siminovitch; Jane Worthington; Lars Klareskog; Peter K Gregersen; Mark J Daly; Robert M Plenge
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.